Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 26.05 million compared to CNY 38.91 million a year ago. Revenue was CNY 26.05 million compared to CNY 38.91 million a year ago. Net loss was CNY 5.83 million compared to CNY 3.07 million a year ago. Basic loss per share from continuing operations was CNY 0.0478 compared to CNY 0.0252 a year ago. Diluted loss per share from continuing operations was CNY 0.0478 compared to CNY 0.0252 a year ago.